| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...512669F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0012669 |
| P932 | PMC publication ID | 2937033 |
| P698 | PubMed publication ID | 20844762 |
| P5875 | ResearchGate publication ID | 46282121 |
| P50 | author | Jose Luis Bocco | Q37838190 |
| P2093 | author name string | Carlos E Argaraña | |
| Patricia Montanaro | |||
| Adela M Luján | |||
| Alejandro J Moyano | |||
| Andrea M Smania | |||
| Claudia Sola | |||
| Liliana Fernández Canigia | |||
| Sofía Feliziani | |||
| P2860 | cites work | Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA | Q27627633 |
| Nucleotides and heteroduplex DNA preserve the active conformation of Pseudomonas aeruginosa MutS by preventing protein oligomerization | Q28366275 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis | Q28492843 | ||
| Role of Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis | Q29346764 | ||
| SIFT: Predicting amino acid changes that affect protein function | Q29547211 | ||
| Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
| Comprehensive transposon mutant library of Pseudomonas aeruginosa | Q29614861 | ||
| Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes | Q29615258 | ||
| Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia | Q29615286 | ||
| Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
| Lung infections associated with cystic fibrosis | Q30080000 | ||
| Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants | Q43851759 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| To be a mutator, or how pathogenic and commensal bacteria can evolve rapidly | Q50132690 | ||
| Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. | Q52575837 | ||
| MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa. | Q52579021 | ||
| A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. | Q53853281 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis | Q61477562 | ||
| Genetic recombination in Pseudomonas aeruginosa | Q73881599 | ||
| Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis | Q80385327 | ||
| Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates | Q82856564 | ||
| Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis | Q84219534 | ||
| Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. | Q30974317 | ||
| Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway | Q33523793 | ||
| Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability | Q33978301 | ||
| Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors. | Q34343418 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis | Q34588476 | ||
| Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. | Q34616140 | ||
| Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections | Q34693974 | ||
| Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection | Q35555504 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis | Q35773317 | ||
| Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. | Q35879111 | ||
| Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation | Q36295397 | ||
| Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region | Q36522578 | ||
| Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients | Q36528781 | ||
| Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa | Q36933558 | ||
| Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. | Q37074619 | ||
| Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains | Q37103851 | ||
| Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients | Q37342706 | ||
| Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections | Q37598703 | ||
| Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome | Q38355288 | ||
| Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif | Q38361436 | ||
| Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis | Q39468249 | ||
| Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro | Q39607438 | ||
| Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates | Q39913368 | ||
| A major Pseudomonas aeruginosa clone common to patients and aquatic habitats | Q39915020 | ||
| Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients | Q39955018 | ||
| Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. | Q40006567 | ||
| Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition | Q40170508 | ||
| Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa | Q40557981 | ||
| Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion | Q40968218 | ||
| Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation | Q41366386 | ||
| Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | Q41825397 | ||
| Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. | Q41937031 | ||
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
| Fidelity of replication of repetitive DNA in mutS and repair proficient Escherichia coli | Q42644527 | ||
| Pseudomonas aeruginosa MutL protein functions in Escherichia coli | Q42932258 | ||
| Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants | Q43216787 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| DNA mismatch repair | Q2984243 | ||
| cystic fibrosis | Q178194 | ||
| antibiotic resistance | Q380775 | ||
| quorum sensing | Q905754 | ||
| P304 | page(s) | e815 | |
| P577 | publication date | 2010-09-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections | |
| P478 | volume | 5 |
| Q35097157 | A long-chain flavodoxin protects Pseudomonas aeruginosa from oxidative stress and host bacterial clearance |
| Q60049204 | Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients |
| Q93270599 | Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations |
| Q50282134 | Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene |
| Q34916610 | Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period |
| Q38686620 | Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient. |
| Q38207078 | Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q34948367 | Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. |
| Q35350270 | Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. |
| Q90050433 | Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections |
| Q26825267 | Culture history and population heterogeneity as determinants of bacterial adaptation: the adaptomics of a single environmental transition |
| Q29346787 | Deep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat shock and oxidative stress response |
| Q34680321 | Elimination of Pseudomonas aeruginosa through Efferocytosis upon Binding to Apoptotic Cells. |
| Q42152337 | Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient. |
| Q40438064 | Environmental Pseudomonads Inhibit Cystic Fibrosis Patient-Derived Pseudomonas aeruginosa. |
| Q34082906 | Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. |
| Q38211644 | Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings |
| Q41812492 | Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa |
| Q34310496 | Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina |
| Q58561024 | Host suppression of quorum sensing during catheter-associated urinary tract infections |
| Q89766030 | Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients |
| Q92676465 | ImuB and ImuC contribute to UV-induced mutagenesis as part of the SOS regulon in Pseudomonas aeruginosa |
| Q36158775 | Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations |
| Q40325143 | Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas aeruginosa |
| Q36450695 | MexXY multidrug efflux system of Pseudomonas aeruginosa |
| Q34753386 | Microbial community adaptation to quaternary ammonium biocides as revealed by metagenomics |
| Q37544527 | Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa |
| Q57806910 | Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts |
| Q34661901 | Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. |
| Q38270707 | Proteomics of hosts and pathogens in cystic fibrosis |
| Q35975439 | Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator |
| Q38268531 | Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. |
| Q36364034 | Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients |
| Q35084559 | Pseudomonas aeruginosa: resistance to the max |
| Q44908378 | Quorum Sensing Down-Regulation Counteracts the Negative Impact of Pseudomonas aeruginosa on CFTR Channel Expression, Function and Rescue in Human Airway Epithelial Cells. |
| Q39767179 | Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair. |
| Q92864466 | Repair Process Impairment by Pseudomonas aeruginosa in Epithelial Tissues: Major Features and Potential Therapeutic Avenues |
| Q42717931 | Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa |
| Q44034811 | Role of a short tandem leucine/arginine repeat in strong mutator phenotype acquisition in a clinical isolate of Salmonella Typhimurium |
| Q35053587 | Simple sequence repeats together with mismatch repair deficiency can bias mutagenic pathways in Pseudomonas aeruginosa during chronic lung infection |
| Q41062024 | Spatial Organization Plasticity as an Adaptive Driver of Surface Microbial Communities |
| Q26747423 | Sub-Optimal Treatment of Bacterial Biofilms |
| Q34860393 | Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium |
| Q92857979 | The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology |
| Q38134377 | The TetR family of regulators |
| Q35482558 | The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria |
Search more.